#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3784	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2945	304.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1851	1851	C	424	C,A	387,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	3784	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2945	304.5	0	HET	.	.	.	C207T	.	207	207	C	874	874	C	336	C,T	174,127	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6006	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4300	335.9	0	.	n	.	0	T695C	SNP	695	695	T	1429	1429	C	447	C,T,A	412,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6006	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4300	335.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2705	2705	C	426	C,G	393,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6006	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4300	335.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2779	2779	A	426	A,C	395,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6006	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4300	335.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3331	3331	C	414	C	375	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6006	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4300	335.9	0	HET	.	.	.	A1638G	.	1638	1638	A	2372	2372	A	400	A,G	297,71	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	432	folP	855	855	100.0	folP.l15.c4.ctg.1	2098	48.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1317	1319	AGC	48;51;51	A;G;C	45;48;47	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1056	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4030	63.0	1	SNP	p	S91F	1	.	.	271	273	TTC	951	953	TTC	74;74;74	T;T;C,A	70;65;69,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1056	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4030	63.0	1	SNP	p	G95N	0	.	.	283	285	GGC	963	965	GGC	79;79;79	G,C;G;C	73,1;74;73	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1056	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	4030	63.0	1	SNP	p	D95G	1	.	.	283	285	GGC	963	965	GGC	79;79;79	G,C;G;C	73,1;74;73	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	306	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1760	41.9	1	SNP	p	G45D	0	.	.	133	135	GGC	721	723	GGC	58;58;58	G;G;C	53;50;54	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	275	206	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1962	24.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	283	1252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	83.9	1	SNP	p	D86N	0	.	.	256	258	GAC	2677	2679	CTG	74;74;74	C;T,G;G	52;46,2;55	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	283	1252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	83.9	1	SNP	p	R87I	0	.	.	259	261	CGT	2674	2676	GCA	74;74;78	G,T;C;A,C	59,1;50;59,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	283	1252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	83.9	1	SNP	p	R87W	0	.	.	259	261	CGT	2674	2676	GCA	74;74;78	G,T;C;A,C	59,1;50;59,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	283	1252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	83.9	1	SNP	p	S87R	1	.	.	259	261	CGT	2674	2676	GCA	74;74;78	G,T;C;A,C	59,1;50;59,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	283	1252	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3598	83.9	1	SNP	p	S88P	0	.	.	262	264	TCC	2671	2673	AGG	78;77;76	A,C;G,A;G	62,1;63,2;68	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	920	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3553	62.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2028	2030	GGC	71;71;71	G;G;C	64;61;56	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1634	1636	GCC	109;110;110	G;C;C	101;102;102	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1637	1639	ATG	111;113;112	A;T,A;G,T	102;103,1;102,2	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1649	1651	ACC	110;110;110	A,C;C,A;C	100,2;102,1;103	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1649	1651	ACC	110;110;110	A,C;C,A;C	100,2;102,1;103	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2150	2152	ACC	93;93;92	A;C,A;C	84;79,1;82	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2204	2206	GCG	82;82;82	G;C,G;G	72;57,1;68	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2204	2206	GCG	82;82;82	G;C,G;G	72;57,1;68	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2327	2329	GGT	57;56;56	G;G,T;T,G	52;49,2;51,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2336	2338	AGC	52;52;52	A;G,C;C,G	28;40,1;30,2	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	858	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2760	72.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2354	2356	CCG	45;45;44	C;C;G,T,C	34;30;37,1,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1126	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3783	70.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2000	2002	CCG	107;107;108	C,T,G;C,A;G,C,T	82,3,2;88,1;73,6,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	454	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2559	42.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	971	971	C	30	C	25	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	640	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	2555	60.4	0	.	p	.	0	I45V	NONSYN	133	135	ATT	893	895	GTT	103;103;103	G;T,G,C;T	97;93,2,1;97	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	640	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	2555	60.4	0	.	p	.	0	G48E	NONSYN	142	144	GGA	902	904	GAA	100;100;100	G;A;A,C	91;91;91,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	640	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	2555	60.4	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1388	1390	AGA	106;109;109	A;G,A;A	97;97,1;99	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	640	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	2555	60.4	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1514	1516	GAA	102;101;98	G,T,A;A;A	96,1,1;97;95	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	640	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	2555	60.4	1	SNP	p	G120K	1	.	.	358	360	AAG	1118	1120	AAG	86;86;85	A,C;A,G;G	77,1;76,1;77	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	640	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	2555	60.4	1	SNP	p	A121N	1	.	.	361	363	AAC	1121	1123	AAC	85;85;84	A;A;C,A	79;79;76,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	640	porB1b	1038	1038	99.61	porB1b.l15.c4.ctg.1	2555	60.4	1	SNP	p	N121D	0	.	.	361	363	AAC	1121	1123	AAC	85;85;84	A;A;C,A	79;79;76,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2422	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5387	108.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	280	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1717	39.8	1	SNP	p	V57M	1	.	.	169	171	ATG	878	880	ATG	81;81;83	A;T;G	73;75;76	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
